GSK-3β Inhibitor XVIII Chemical Properties

Boiling point:

632.3±65.0 °C(Predicted)

Density 

1.358±0.06 g/cm3(Predicted)

storage temp. 

+2C to +8C

solubility 

DMSO: soluble

pka

6?+-.0.10(Predicted)

form 

White solid

GSK-3β Inhibitor XVIII Usage And Synthesis

Description

GSK3β inhibitor XVIII is an inhibitor of glycogen synthase kinase 3β (GSK3β; IC₅₀ = 64 nM). It induces expression of a luciferase reporter in HEK293 cells expressing wild-type Wnt (EC₅₀ = ~1.25 μM) but not in cells expressing a β-catenin/TCF binding site-mutant Wnt. GSK3β inhibitor XVIII increases β-catenin accumulation in the nucleus of HEK293 cells. It induces proliferation of R7T1 β-cells (EC₅₀ = 1,143 nM), an effect that can be blocked by the COX and Wnt signaling inhibitor sulindac , and rat primary β-cells.

GSK-3β Inhibitor XVIII(1139875-74-3)Related Product Information

• 2-[(6-Amino-9H-purin-9-yl)methyl]-5-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone
• N-[4-[5-(1,3-BENZODIOXOL-5-YL)-3-METHOXY-1H-1,2,4-TRIAZOL-1-YL]PHENYL]-2-(PHENYLTHIO)ACETAMIDE
• NSC 23766 TETRAHYDROCHLORIDE
• NSC697923
• MIF Antagonist, ISO-1
• Pictilisib
• JNJ-10198409
• Chk2 Inhibitor
• Trolox
• C2 CERAMIDE
• Motesanib
• PD 173074
• Compound 28
• Glycogen Phosphorylase Inhibitor
• MMP-9 INHIBITOR I
• Compound 23
• ERK Inhibitor
• 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-2-CARBOXYLIC ACID